Tong Li
Direktor/Vorstandsmitglied bei Shenzhen GTJA Investment Group Co., Ltd.
Aktive Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Feng Li | M | 52 |
Beijing Mabworks Biotech Co., Ltd.
 Beijing Mabworks Biotech Co., Ltd. Pharmaceuticals: MajorHealth Technology Beijing Mabworks Biotech Co., Ltd. engages in the discovery, development, manufacturing and commercialization of therapeutic antibodies. It develops antibody drugs and macromolecular biological drugs. The firm’s products include MIL60, MIL62, MIL86, MBS301, MIL77, and MIL93. The company was founded on February 27, 2003 and is headquartered in Beijing, China. | 13 Jahre |
| Xue Feng Hu | M | 54 |
Beijing GTJA Asset Management Co., Ltd.
 Beijing GTJA Asset Management Co., Ltd. Financial ConglomeratesFinance Beijing GTJA Asset Management Co., Ltd. engages in the provision of investment services. Its business scope includes investment information consulting; investment in science and technology enterprises, entrepreneurial enterprises, and other project investments; and asset management. The company was founded on November 6, 2007 and is headquartered in Beijing, China.
Shenzhen GTJA Investment Group Co., Ltd.
 Shenzhen GTJA Investment Group Co., Ltd. Investment ManagersFinance Shenzhen GTJA Investment Group Co., Ltd. (Shenzhen GTJA Investment) is an independent private equity firm founded in 2001. The firm is headquartered in Shenzhen, China. | - |
| Xiao Jun Zeng | M | 50 |
Beijing GTJA Asset Management Co., Ltd.
Beijing GTJA Asset Management Co., Ltd. Financial ConglomeratesFinance Beijing GTJA Asset Management Co., Ltd. engages in the provision of investment services. Its business scope includes investment information consulting; investment in science and technology enterprises, entrepreneurial enterprises, and other project investments; and asset management. The company was founded on November 6, 2007 and is headquartered in Beijing, China.
Shenzhen GTJA Investment Group Co., Ltd.
Shenzhen GTJA Investment Group Co., Ltd. Investment ManagersFinance Shenzhen GTJA Investment Group Co., Ltd. (Shenzhen GTJA Investment) is an independent private equity firm founded in 2001. The firm is headquartered in Shenzhen, China. | - |
| Bo Yan Zhang | M | 59 |
Beijing Mabworks Biotech Co., Ltd.
Beijing Mabworks Biotech Co., Ltd. Pharmaceuticals: MajorHealth Technology Beijing Mabworks Biotech Co., Ltd. engages in the discovery, development, manufacturing and commercialization of therapeutic antibodies. It develops antibody drugs and macromolecular biological drugs. The firm’s products include MIL60, MIL62, MIL86, MBS301, MIL77, and MIL93. The company was founded on February 27, 2003 and is headquartered in Beijing, China. | 11 Jahre |
| Lei Yang | M | - |
Shenzhen GTJA Investment Group Co., Ltd.
Shenzhen GTJA Investment Group Co., Ltd. Investment ManagersFinance Shenzhen GTJA Investment Group Co., Ltd. (Shenzhen GTJA Investment) is an independent private equity firm founded in 2001. The firm is headquartered in Shenzhen, China. | - |
| Wen Qi Hu | M | 62 |
Beijing Mabworks Biotech Co., Ltd.
Beijing Mabworks Biotech Co., Ltd. Pharmaceuticals: MajorHealth Technology Beijing Mabworks Biotech Co., Ltd. engages in the discovery, development, manufacturing and commercialization of therapeutic antibodies. It develops antibody drugs and macromolecular biological drugs. The firm’s products include MIL60, MIL62, MIL86, MBS301, MIL77, and MIL93. The company was founded on February 27, 2003 and is headquartered in Beijing, China. | 7 Jahre |
| Yiu Leung Cheung | M | 64 |
Beijing Mabworks Biotech Co., Ltd.
Beijing Mabworks Biotech Co., Ltd. Pharmaceuticals: MajorHealth Technology Beijing Mabworks Biotech Co., Ltd. engages in the discovery, development, manufacturing and commercialization of therapeutic antibodies. It develops antibody drugs and macromolecular biological drugs. The firm’s products include MIL60, MIL62, MIL86, MBS301, MIL77, and MIL93. The company was founded on February 27, 2003 and is headquartered in Beijing, China. | 3 Jahre |
| Hong Wu Niu | M | - |
Shenzhen GTJA Investment Group Co., Ltd.
Shenzhen GTJA Investment Group Co., Ltd. Investment ManagersFinance Shenzhen GTJA Investment Group Co., Ltd. (Shenzhen GTJA Investment) is an independent private equity firm founded in 2001. The firm is headquartered in Shenzhen, China. | - |
| Hai Jiao Wang | M | 43 |
Shenzhen GTJA Investment Group Co., Ltd.
Shenzhen GTJA Investment Group Co., Ltd. Investment ManagersFinance Shenzhen GTJA Investment Group Co., Ltd. (Shenzhen GTJA Investment) is an independent private equity firm founded in 2001. The firm is headquartered in Shenzhen, China. | - |
| Zhong Tao Wu | M | - |
Shenzhen GTJA Investment Group Co., Ltd.
Shenzhen GTJA Investment Group Co., Ltd. Investment ManagersFinance Shenzhen GTJA Investment Group Co., Ltd. (Shenzhen GTJA Investment) is an independent private equity firm founded in 2001. The firm is headquartered in Shenzhen, China. | - |
| Jian Lin Yu | M | - |
Shenzhen GTJA Investment Group Co., Ltd.
Shenzhen GTJA Investment Group Co., Ltd. Investment ManagersFinance Shenzhen GTJA Investment Group Co., Ltd. (Shenzhen GTJA Investment) is an independent private equity firm founded in 2001. The firm is headquartered in Shenzhen, China. | - |
| Wei Zhang | F | - |
Shenzhen GTJA Investment Group Co., Ltd.
Shenzhen GTJA Investment Group Co., Ltd. Investment ManagersFinance Shenzhen GTJA Investment Group Co., Ltd. (Shenzhen GTJA Investment) is an independent private equity firm founded in 2001. The firm is headquartered in Shenzhen, China. | - |
| Heng Tang | M | - |
Shenzhen GTJA Investment Group Co., Ltd.
Shenzhen GTJA Investment Group Co., Ltd. Investment ManagersFinance Shenzhen GTJA Investment Group Co., Ltd. (Shenzhen GTJA Investment) is an independent private equity firm founded in 2001. The firm is headquartered in Shenzhen, China. | - |
| Gui Ling Tan | M | 57 |
Shenzhen GTJA Investment Group Co., Ltd.
Shenzhen GTJA Investment Group Co., Ltd. Investment ManagersFinance Shenzhen GTJA Investment Group Co., Ltd. (Shenzhen GTJA Investment) is an independent private equity firm founded in 2001. The firm is headquartered in Shenzhen, China. | - |
| Ren Yu Li | M | 63 |
Beijing Mabworks Biotech Co., Ltd.
Beijing Mabworks Biotech Co., Ltd. Pharmaceuticals: MajorHealth Technology Beijing Mabworks Biotech Co., Ltd. engages in the discovery, development, manufacturing and commercialization of therapeutic antibodies. It develops antibody drugs and macromolecular biological drugs. The firm’s products include MIL60, MIL62, MIL86, MBS301, MIL77, and MIL93. The company was founded on February 27, 2003 and is headquartered in Beijing, China. | 4 Jahre |
| Tao Zhu | M | 51 |
Beijing Mabworks Biotech Co., Ltd.
Beijing Mabworks Biotech Co., Ltd. Pharmaceuticals: MajorHealth Technology Beijing Mabworks Biotech Co., Ltd. engages in the discovery, development, manufacturing and commercialization of therapeutic antibodies. It develops antibody drugs and macromolecular biological drugs. The firm’s products include MIL60, MIL62, MIL86, MBS301, MIL77, and MIL93. The company was founded on February 27, 2003 and is headquartered in Beijing, China. | 4 Jahre |
| Yu Huang | M | 53 |
Shenzhen GTJA Investment Group Co., Ltd.
Shenzhen GTJA Investment Group Co., Ltd. Investment ManagersFinance Shenzhen GTJA Investment Group Co., Ltd. (Shenzhen GTJA Investment) is an independent private equity firm founded in 2001. The firm is headquartered in Shenzhen, China. | 17 Jahre |
| Tian Wang | M | 33 |
Beijing Mabworks Biotech Co., Ltd.
Beijing Mabworks Biotech Co., Ltd. Pharmaceuticals: MajorHealth Technology Beijing Mabworks Biotech Co., Ltd. engages in the discovery, development, manufacturing and commercialization of therapeutic antibodies. It develops antibody drugs and macromolecular biological drugs. The firm’s products include MIL60, MIL62, MIL86, MBS301, MIL77, and MIL93. The company was founded on February 27, 2003 and is headquartered in Beijing, China. | 5 Jahre |
| Da Jian Cai | M | - |
Beijing GTJA Asset Management Co., Ltd.
Beijing GTJA Asset Management Co., Ltd. Financial ConglomeratesFinance Beijing GTJA Asset Management Co., Ltd. engages in the provision of investment services. Its business scope includes investment information consulting; investment in science and technology enterprises, entrepreneurial enterprises, and other project investments; and asset management. The company was founded on November 6, 2007 and is headquartered in Beijing, China.
Shenzhen GTJA Investment Group Co., Ltd.
Shenzhen GTJA Investment Group Co., Ltd. Investment ManagersFinance Shenzhen GTJA Investment Group Co., Ltd. (Shenzhen GTJA Investment) is an independent private equity firm founded in 2001. The firm is headquartered in Shenzhen, China. | - |
| Jing Zhang | F | 42 |
Beijing Mabworks Biotech Co., Ltd.
Beijing Mabworks Biotech Co., Ltd. Pharmaceuticals: MajorHealth Technology Beijing Mabworks Biotech Co., Ltd. engages in the discovery, development, manufacturing and commercialization of therapeutic antibodies. It develops antibody drugs and macromolecular biological drugs. The firm’s products include MIL60, MIL62, MIL86, MBS301, MIL77, and MIL93. The company was founded on February 27, 2003 and is headquartered in Beijing, China. | 11 Jahre |
| Pei Ye | F | 61 |
Beijing Mabworks Biotech Co., Ltd.
Beijing Mabworks Biotech Co., Ltd. Pharmaceuticals: MajorHealth Technology Beijing Mabworks Biotech Co., Ltd. engages in the discovery, development, manufacturing and commercialization of therapeutic antibodies. It develops antibody drugs and macromolecular biological drugs. The firm’s products include MIL60, MIL62, MIL86, MBS301, MIL77, and MIL93. The company was founded on February 27, 2003 and is headquartered in Beijing, China. | 12 Jahre |
| Yan Qi | F | 54 |
Beijing Mabworks Biotech Co., Ltd.
Beijing Mabworks Biotech Co., Ltd. Pharmaceuticals: MajorHealth Technology Beijing Mabworks Biotech Co., Ltd. engages in the discovery, development, manufacturing and commercialization of therapeutic antibodies. It develops antibody drugs and macromolecular biological drugs. The firm’s products include MIL60, MIL62, MIL86, MBS301, MIL77, and MIL93. The company was founded on February 27, 2003 and is headquartered in Beijing, China. | 17 Jahre |
| Hui Fang Liu | M | 64 |
Beijing Mabworks Biotech Co., Ltd.
Beijing Mabworks Biotech Co., Ltd. Pharmaceuticals: MajorHealth Technology Beijing Mabworks Biotech Co., Ltd. engages in the discovery, development, manufacturing and commercialization of therapeutic antibodies. It develops antibody drugs and macromolecular biological drugs. The firm’s products include MIL60, MIL62, MIL86, MBS301, MIL77, and MIL93. The company was founded on February 27, 2003 and is headquartered in Beijing, China. | 12 Jahre |
| Qi Li | M | 44 |
Beijing Mabworks Biotech Co., Ltd.
Beijing Mabworks Biotech Co., Ltd. Pharmaceuticals: MajorHealth Technology Beijing Mabworks Biotech Co., Ltd. engages in the discovery, development, manufacturing and commercialization of therapeutic antibodies. It develops antibody drugs and macromolecular biological drugs. The firm’s products include MIL60, MIL62, MIL86, MBS301, MIL77, and MIL93. The company was founded on February 27, 2003 and is headquartered in Beijing, China. | 3 Jahre |
| Jin Jin Liang | M | 55 |
Beijing Mabworks Biotech Co., Ltd.
Beijing Mabworks Biotech Co., Ltd. Pharmaceuticals: MajorHealth Technology Beijing Mabworks Biotech Co., Ltd. engages in the discovery, development, manufacturing and commercialization of therapeutic antibodies. It develops antibody drugs and macromolecular biological drugs. The firm’s products include MIL60, MIL62, MIL86, MBS301, MIL77, and MIL93. The company was founded on February 27, 2003 and is headquartered in Beijing, China. | 5 Jahre |
| Dipak Chand Jain | M | 67 |
China Europe International Business School
| 7 Jahre |
| Ting Li | F | 35 |
Beijing Mabworks Biotech Co., Ltd.
Beijing Mabworks Biotech Co., Ltd. Pharmaceuticals: MajorHealth Technology Beijing Mabworks Biotech Co., Ltd. engages in the discovery, development, manufacturing and commercialization of therapeutic antibodies. It develops antibody drugs and macromolecular biological drugs. The firm’s products include MIL60, MIL62, MIL86, MBS301, MIL77, and MIL93. The company was founded on February 27, 2003 and is headquartered in Beijing, China. | 4 Jahre |
| Zhan Chao Liang | M | 40 |
Beijing Mabworks Biotech Co., Ltd.
Beijing Mabworks Biotech Co., Ltd. Pharmaceuticals: MajorHealth Technology Beijing Mabworks Biotech Co., Ltd. engages in the discovery, development, manufacturing and commercialization of therapeutic antibodies. It develops antibody drugs and macromolecular biological drugs. The firm’s products include MIL60, MIL62, MIL86, MBS301, MIL77, and MIL93. The company was founded on February 27, 2003 and is headquartered in Beijing, China. | 8 Jahre |
| Wing Sze Yu | F | 41 |
Beijing Mabworks Biotech Co., Ltd.
Beijing Mabworks Biotech Co., Ltd. Pharmaceuticals: MajorHealth Technology Beijing Mabworks Biotech Co., Ltd. engages in the discovery, development, manufacturing and commercialization of therapeutic antibodies. It develops antibody drugs and macromolecular biological drugs. The firm’s products include MIL60, MIL62, MIL86, MBS301, MIL77, and MIL93. The company was founded on February 27, 2003 and is headquartered in Beijing, China. | - |
| Pascal Lamy | M | - |
China Europe International Business School
| 6 Jahre |
| Qing Huang | F | 49 |
Shenzhen GTJA Investment Group Co., Ltd.
Shenzhen GTJA Investment Group Co., Ltd. Investment ManagersFinance Shenzhen GTJA Investment Group Co., Ltd. (Shenzhen GTJA Investment) is an independent private equity firm founded in 2001. The firm is headquartered in Shenzhen, China. | - |
| Wei Cai | M | 48 |
Shenzhen GTJA Investment Group Co., Ltd.
Shenzhen GTJA Investment Group Co., Ltd. Investment ManagersFinance Shenzhen GTJA Investment Group Co., Ltd. (Shenzhen GTJA Investment) is an independent private equity firm founded in 2001. The firm is headquartered in Shenzhen, China. | - |
| Cai Qin Chen | M | - |
Shenzhen GTJA Investment Group Co., Ltd.
Shenzhen GTJA Investment Group Co., Ltd. Investment ManagersFinance Shenzhen GTJA Investment Group Co., Ltd. (Shenzhen GTJA Investment) is an independent private equity firm founded in 2001. The firm is headquartered in Shenzhen, China. | - |
| Bo Ban | F | - |
Shenzhen GTJA Investment Group Co., Ltd.
Shenzhen GTJA Investment Group Co., Ltd. Investment ManagersFinance Shenzhen GTJA Investment Group Co., Ltd. (Shenzhen GTJA Investment) is an independent private equity firm founded in 2001. The firm is headquartered in Shenzhen, China. | - |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Xin Qu | F | 61 |
Beijing Mabworks Biotech Co., Ltd.
Beijing Mabworks Biotech Co., Ltd. Pharmaceuticals: MajorHealth Technology Beijing Mabworks Biotech Co., Ltd. engages in the discovery, development, manufacturing and commercialization of therapeutic antibodies. It develops antibody drugs and macromolecular biological drugs. The firm’s products include MIL60, MIL62, MIL86, MBS301, MIL77, and MIL93. The company was founded on February 27, 2003 and is headquartered in Beijing, China. | - |
| Yuan Yu Lin | M | 47 |
China Europe International Business School
| 2 Jahre |
| Yun Gao | F | 35 |
China Europe International Business School
| 2 Jahre |
| Yan Yan Zhang | F | 42 |
China Europe International Business School
| 2 Jahre |
| Cheng Hu Shi | M | 49 |
China Europe International Business School
| 2 Jahre |
| Min Zhao | M | 51 |
Chang'an University
| 4 Jahre |
| Yui Yu | M | 41 |
China Europe International Business School
| 2 Jahre |
| Wei Sun | M | 44 |
China Europe International Business School
| 2 Jahre |
| Li Ping Tian | F | 57 |
China Europe International Business School
| 2 Jahre |
| Jie Han | M | 49 |
Chang'an University
| 4 Jahre |
| Yun Qing Wang | M | 40 |
China Europe International Business School
| 2 Jahre |
| Ma Yong | M | 53 |
China Europe International Business School
| 2 Jahre |
| Wei Li | M | 45 |
China Europe International Business School
| 2 Jahre |
| Zi Quan Wang | M | 57 |
China Europe International Business School
| 2 Jahre |
| Qingda Heng | M | 49 |
China Europe International Business School
| 2 Jahre |
| Xin Hao He | M | 43 |
China Europe International Business School
| 2 Jahre |
| Patrick Harris | M | - |
China Europe International Business School
| 1 Jahre |
| Feng Yu | M | 47 |
China Europe International Business School
| 2 Jahre |
| Yi Gang Xu | M | 50 |
China Europe International Business School
| 2 Jahre |
| Chunfeng Huang | M | 47 |
China Europe International Business School
| 1 Jahre |
| Hui Kong | M | 37 |
China Europe International Business School
| 2 Jahre |
| Peng Cui | M | 47 |
China Europe International Business School
| 2 Jahre |
| Li Quan Liang | M | 48 |
Chang'an University
| 4 Jahre |
| Zhen Yang | M | 45 |
Chang'an University
| 4 Jahre |
| Changzheng Chen | M | 44 |
China Europe International Business School
| 2 Jahre |
| Guang Xian Zhu | M | 46 |
China Europe International Business School
| 2 Jahre |
| Chen Wei | M | 38 |
China Europe International Business School
| 2 Jahre |
| Nini Mu | F | - |
China Europe International Business School
| 2 Jahre |
| Jiting Peng | M | - |
China Europe International Business School
| 2 Jahre |
| Jun Xu | M | 50 |
China Europe International Business School
| 2 Jahre |
| Xi Chen Wang | M | 49 |
China Europe International Business School
| 2 Jahre |
| Kejia Li | M | - |
China Europe International Business School
| 1 Jahre |
| Yu Min Cai | F | 41 |
China Europe International Business School
| 2 Jahre |
| Hong Wang | M | 47 |
Chang'an University
| 4 Jahre |
| Lu Yi Li | F | 44 |
China Europe International Business School
| 2 Jahre |
| Ya Yun Li | F | - |
China Europe International Business School
| 1 Jahre |
| Cheng Lien Chen | M | 45 |
China Europe International Business School
| 2 Jahre |
| Ji Zhang | M | 51 |
Chang'an University
| 4 Jahre |
| Zhimeng Zhao | M | 53 |
Chang'an University
| 4 Jahre |
| Qiang Shi | M | 41 |
China Europe International Business School
| 1 Jahre |
| Pei Wang | M | 51 |
Chang'an University
| 4 Jahre |
| Yu Ping Xie | F | 50 |
China Europe International Business School
| 2 Jahre |
| Zhi Yong Lai | M | 52 |
China Europe International Business School
| 2 Jahre |
| Ming Tian | M | 63 |
China Europe International Business School
| 3 Jahre |
| Min Wu | M | 55 |
China Europe International Business School
| 2 Jahre |
| Kuan Yun Xia | M | 62 |
China Europe International Business School
| 2 Jahre |
| Li Cheng | M | 42 |
China Europe International Business School
| 2 Jahre |
| Yimin Zhu | M | 63 |
Chang'an University
| 4 Jahre |
| Lun Wong | M | 36 |
China Europe International Business School
| 2 Jahre |
| Chao Jie Yang | F | 54 |
Chang'an University
| 4 Jahre |
| Jing Lv | M | 50 |
China Europe International Business School
| 2 Jahre |
| Bin Xi | M | 48 |
China Europe International Business School
| 2 Jahre |
| Ming Ge | M | 45 |
China Europe International Business School
| 2 Jahre |
| Guang Qing Sun | M | 38 |
China Europe International Business School
| 2 Jahre |
| Hai Qiu Guo | M | 49 |
China Europe International Business School
| 2 Jahre |
| Zhi Hong Zhang | M | 54 |
China Europe International Business School
| 1 Jahre |
| António José Maria D'Ávila Duro de Mello Campello | M | - |
China Europe International Business School
| - |
| Yu Ping He | M | 51 |
China Europe International Business School
| 2 Jahre |
| Xin Guan | F | 42 |
China Europe International Business School
| 2 Jahre |
| Ting Yan Chau | M | 66 |
China Europe International Business School
| 2 Jahre |
| Liang Li | M | 51 |
Chang'an University
| 1 Jahre |
| Hui Peng Zhang | M | 42 |
China Europe International Business School
| 2 Jahre |
| Hung Man Wang | M | 36 |
China Europe International Business School
| 2 Jahre |
| Zhen Hui Wang | M | 49 |
China Europe International Business School
| 2 Jahre |
| Xu Zhang | M | 53 |
China Europe International Business School
| 2 Jahre |
| Wuchang Lin | M | 48 |
Chang'an University
| 4 Jahre |
Statistik
| Land | Beziehungen | % des Gesamten |
|---|---|---|
| China | 100 | 100,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen